RetinalGenix Technologies (RTGN) Assets Growth (1y) (2021 - 2026)
RetinalGenix Technologies (RTGN) Assets Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.35% |
| Dec 31, 2025 | 40.78% |
| Sep 30, 2025 | -92.12% |
| Jun 30, 2025 | -90.36% |
| Mar 31, 2025 | -76.38% |
| Dec 31, 2024 | 9,480.77% |
| Sep 30, 2024 | 39,390.67% |
| Jun 30, 2024 | 4,006.61% |
| Mar 31, 2024 | 555.98% |
| Dec 31, 2023 | -46.94% |
| Sep 30, 2023 | -94.25% |
| Jun 30, 2023 | 7,748.15% |
| Mar 31, 2023 | 201.41% |
| Dec 31, 2022 | -94.06% |
| Sep 30, 2022 | -89.30% |
| Dec 31, 2021 | -91.90% |